We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$811M
Cap. Flow
+$429M
Cap. Flow %
2.05%
Top 10 Hldgs %
15.16%
Holding
2,330
New
84
Increased
1,228
Reduced
936
Closed
75

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$42M
2
VZ icon
Verizon
VZ
+$41.3M
3
NEE icon
NextEra Energy
NEE
+$28.9M
4
CHL
China Mobile Limited
CHL
+$24M
5
AMZN icon
Amazon
AMZN
+$22.3M

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$48.9M
2
MON
Monsanto Co
MON
+$40.2M
3
PG icon
Procter & Gamble
PG
+$27.1M
4
MMM icon
3M
MMM
+$26.7M
5
IBM icon
IBM
IBM
+$24M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Financials 17.23%
3 Healthcare 12.98%
4 Consumer Discretionary 10.12%
5 Industrials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASH icon
976
Ashland
ASH
$3.33B
$2.25M 0.01%
28,776
-1,333
-4% -$99.3K
QVCGA
977
DELISTED
QVC Group Inc Series A
QVCGA
$2.25M 0.01%
2,183
-273
-11% -$302K
SON icon
978
Sonoco
SON
$5.57B
$2.24M 0.01%
42,628
-13,634
-24% -$701K
FICO icon
979
Fair Isaac
FICO
$24.3B
$2.23M 0.01%
11,561
-509
-4% -$92.2K
TARO
980
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2.23M 0.01%
19,266
-6,757
-26% -$742K
DECK icon
981
Deckers Outdoor
DECK
$13.2B
$2.23M 0.01%
118,428
+40,536
+52% +$701K
SEE
982
DELISTED
Sealed Air
SEE
$2.23M 0.01%
52,444
-2,839
-5% -$125K
VRE
983
DELISTED
Veris Residential
VRE
$2.23M 0.01%
109,724
+65,988
+151% +$1.22M
INGN icon
984
Inogen
INGN
$175M
$2.22M 0.01%
11,915
+638
+6% +$106K
CSL icon
985
Carlisle Companies
CSL
$14.6B
$2.21M 0.01%
20,449
-3,220
-14% -$341K
GNTX icon
986
Gentex
GNTX
$4.97B
$2.21M 0.01%
96,065
+12,051
+14% +$286K
OHI icon
987
Omega Healthcare
OHI
$15.1B
$2.21M 0.01%
71,284
+323
+0.5% +$9.23K
HDS
988
DELISTED
HD Supply Holdings, Inc.
HDS
$2.2M 0.01%
51,314
+1,911
+4% +$77.4K
FLS icon
989
Flowserve
FLS
$9.71B
$2.2M 0.01%
54,475
-3,450
-6% -$150K
THO icon
990
Thor Industries
THO
$3.9B
$2.19M 0.01%
22,539
+81
+0.4% +$8.26K
NWLI
991
DELISTED
National Western Life Group, Inc. Class A
NWLI
$2.19M 0.01%
7,138
+128
+2% +$39.9K
VER
992
DELISTED
VEREIT, Inc.
VER
$2.18M 0.01%
58,589
+3,892
+7% +$137K
ENOV icon
993
Enovis
ENOV
$1.68B
$2.17M 0.01%
41,112
+10,528
+34% +$569K
BRX icon
994
Brixmor Property Group
BRX
$9.67B
$2.16M 0.01%
123,773
-37,633
-23% -$585K
FLR icon
995
Fluor
FLR
$7.01B
$2.16M 0.01%
44,208
-490
-1% -$25.7K
GGG icon
996
Graco
GGG
$12.9B
$2.15M 0.01%
47,639
+1,461
+3% +$67K
ATR icon
997
AptarGroup
ATR
$8.55B
$2.15M 0.01%
23,019
-1,913
-8% -$178K
AVNS
998
DELISTED
Avanos Medical
AVNS
$2.15M 0.01%
37,461
+2,106
+6% +$111K
MOH icon
999
Molina Healthcare
MOH
$10.2B
$2.14M 0.01%
21,874
+182
+0.8% +$15.9K
RDC
1000
DELISTED
Rowan Companies Plc
RDC
$2.14M 0.01%
131,666
+27,608
+27% +$415K

Similar funds

Aperio Group's Q2 2018 Portfolio in Review

As of Q2 2018, Aperio Group held 2,330 positions worth $20.9B, up 4% from $20.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aperio Group's Q2 2018 filing shows 84 new, 1,228 increased, 936 reduced and 75 closed positions. Its largest new stake was Evergy: 203,701 shares worth $11.4M. The largest sale was Time Warner Inc, an estimated $48.9M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q2 2018 buy was Evergy: 203,701 shares worth $11.4M.
  • Aperio Group added most to Pfizer in Q2 2018, an estimated $42M increase.
  • Aperio Group's biggest Q2 2018 reduction was Procter & Gamble, cutting an estimated $27.1M.
  • Aperio Group fully exited Time Warner Inc in Q2 2018, selling an estimated $48.9M.
  • Aperio Group's ten largest holdings make up 15% of its $20.9B portfolio in Q2 2018.
  • Aperio Group opened 84 new positions and closed 75 in Q2 2018.
  • Aperio Group's portfolio value rose 4% quarter-over-quarter to $20.9B.

Based on Aperio Group's 13F filing for Q2 2018, filed 30 Jul 2018.